fluorouracil has been researched along with busulfan in 62 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 35 (56.45) | 18.7374 |
1990's | 3 (4.84) | 18.2507 |
2000's | 9 (14.52) | 29.6817 |
2010's | 13 (20.97) | 24.3611 |
2020's | 2 (3.23) | 2.80 |
Authors | Studies |
---|---|
Larrick, JW; Wang, H; Wang, Y; Wright, SC; Ye, W; Yuan, H | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Benfenati, E; Raska, I; Toropov, AA; Toropova, AP | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Chu, BC; Lawley, PD | 1 |
Botnick, LE; Hannon, EC; Hellman, S | 2 |
Michalová, K; Musilová, J; Urban, J | 1 |
Denck, H; Karrer, K; Pridun, N; Sighart, H | 1 |
Marsh, JC | 1 |
Blau, HJ | 1 |
Morley, AA; Trainor, KJ | 1 |
Jeljaszewicz, J; Szmigielski, S | 1 |
Ehrsson, H; Eksborg, S | 1 |
San Martín de Viale, LC; Wainstok de Calmanovici, R | 1 |
Adam, J; Rosendaal, M | 1 |
Aabo, K; Dombernowsky, P; Hald, I; Hansen, HH; Hørbov, S; Lundvall, F; Nielsen, NC; Sørensen, BL; Sørensen, HM | 1 |
Emma, DA; Evans, MJ; Hooker, JL; Johnke, RM; Kovacs, CJ | 1 |
Hardt, F | 1 |
Murphy, GP | 1 |
Almeyda, J; Levantine, A | 1 |
Sugiura, K | 1 |
Cappuccino, JG; Schmid, FA; Stock, CC; Tarnowski, GS | 1 |
Bradner, WT; Pindell, MH | 1 |
Maisin, H | 1 |
Armstrong, JG | 1 |
Ehling, UH | 1 |
Hoshi, A; Kanzawa, F; Kuretani, K | 1 |
Hebborn, P; Mishra, LC | 1 |
Berndt, H; Rieche, K | 1 |
Hoshi, A; Kanzawa, F; Kumagai, K; Kuretani, K | 1 |
Karsten, C; Krüger, C; Scherf, HR | 1 |
Schmähl, D | 1 |
Schwartz, E | 1 |
Kumkumadzhian, VA; Papoian, SA | 1 |
Lohrmann, HP; Schreml, W | 1 |
Grönroos, M; Kauppila, A; Kauppila, O; Nieminen, U; Saksela, E; Väyrynen, M | 1 |
Garnick, MB; Griffin, JD | 1 |
Down, JD; Ploemacher, RE | 1 |
Navarra, P; Preziosi, P | 1 |
Fukuda, H; Kunitoh, H; Saijo, N; Sekine, I | 1 |
Beijnen, JH; Mathôt, RA; Schellens, JH; van den Bongard, HJ | 1 |
Chapel, S; Hohl, RJ; McGuire, EM; Schmidt, RL; Veng-Pedersen, P; Widness, JA | 1 |
Chu, J; Ding, S; Liu, A; Wang, S; Xu, S; Zhao, J | 1 |
Chu, JX; Ding, SL; Liu, AR; Wang, SP; Xu, SC; Zhao, JM | 1 |
GOLDENBERG, DM | 1 |
Cui, G; Guo, X; Liu, L; Qi, Z; Qin, J; Zhang, Y | 1 |
Ayuk, F; Bokemeyer, C; Brammer, I; Kröger, N; Mina, S; Nitsch, E; Pace, A; Schuch, G; Zander, A | 1 |
Abedi-Valugerdi, M; Hassan, M; Pillai, PR; Sadeghi, B; Wolfsberger, J; Zhao, Y; Zheng, W | 1 |
Husseini, GA; Ibrahim, M; Sabouni, R | 1 |
Becker, G; Levêque, D | 1 |
Chen, J; Feng, X; Hormaechea-Agulla, D; King, KY; Maharjan, M; Matatall, KA; Young, N | 1 |
Bonnabry, P; Fleury-Souverain, S; Guillarme, D; Maurin, J; Rudaz, S | 1 |
11 review(s) available for fluorouracil and busulfan
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The effects of cancer chemotherapeutic agents on normal hematopoietic precursor cells: a review.
Topics: Alkylating Agents; Animals; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Asparaginase; Benzamides; Busulfan; Carmustine; Cisplatin; Cyclophosphamide; Cytarabine; Drug Evaluation, Preclinical; Erythrocytes; Fluorouracil; Hematopoietic Stem Cells; Humans; Hydroxyurea; Lomustine; Methotrexate; Nitrogen Mustard Compounds; Spleen; Vinca Alkaloids | 1976 |
Drug level monitoring: cytostatics.
Topics: Alkylating Agents; Aminoacridines; Amsacrine; Anthraquinones; Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; Bleomycin; Busulfan; Chlorambucil; Chromatography, Gas; Chromatography, Liquid; Cisplatin; Cyclophosphamide; Cytarabine; Fluorouracil; Humans; Mass Spectrometry; Melphalan; Methotrexate; Mitomycins; Monitoring, Physiologic; Nitrosourea Compounds; Podophyllotoxin; Purines; Thiotepa; Vinca Alkaloids | 1985 |
Drug reactions. XXIV. Cutaneous reactions to cytostatic agents.
Topics: Alopecia; Aminopterin; Antineoplastic Agents; Asparaginase; Azathioprine; Bleomycin; Busulfan; Chlorambucil; Cyclophosphamide; Dactinomycin; Drug Eruptions; Erythema; Fluorouracil; Gynecomastia; Humans; Hydroxyurea; Methotrexate; Photosensitivity Disorders; Pigmentation Disorders; Radiation Injuries; Stomatitis; Vinblastine | 1974 |
[Side-effects of cytostatic therapy with special reference to potential carcinogenic effects].
Topics: Alkylating Agents; Animals; Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; Busulfan; Fluorouracil; Hemangiosarcoma; Mercaptopurine; Mitomycins; Neoplasms; Neoplasms, Experimental; Podophyllin; Rats; Sarcoma, Experimental; Thiotepa; Vinblastine | 1971 |
Cytotoxic drugs and the granulopoietic system.
Topics: Animals; Antibiotics, Antineoplastic; Bleomycin; Bone Marrow; Busulfan; Chlorambucil; Colony-Forming Units Assay; Cyclophosphamide; Cytarabine; Cytotoxins; Dactinomycin; Fluorouracil; Granulocytes; Hematopoietic Stem Cells; Hematopoietic System; Humans; Methotrexate; Nitrogen Mustard Compounds; Nitrosourea Compounds; Vinblastine | 1982 |
Eye toxicity of cancer chemotherapy: a review of the literature.
Topics: Adrenal Cortex Hormones; Antineoplastic Agents; Busulfan; Drug Therapy, Combination; Estrogen Antagonists; Estrogens; Eye Diseases; Fluorouracil; Graft vs Host Reaction; Humans; Mitobronitol; Vinca Alkaloids | 1981 |
Cancer chemotherapy in the elderly.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Anthraquinones; Antineoplastic Agents; Breast Neoplasms; Busulfan; Daunorubicin; Doxorubicin; Etoposide; Female; Fluorouracil; Heart; Hematologic Neoplasms; Humans; Lung; Male; Middle Aged; Neoplasms; Pyrazoles | 1998 |
Pharmacokinetically guided administration of chemotherapeutic agents.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Busulfan; Carboplatin; Cisplatin; Etoposide; Fluorouracil; Humans; Topotecan | 2000 |
Anti-cancer Drug Delivery Using Metal Organic Frameworks (MOFs).
Topics: Antineoplastic Agents; Busulfan; Camptothecin; Cell Line, Tumor; Doxorubicin; Drug Carriers; Fluorouracil; Humans; Nanoparticles; Organometallic Compounds; Organoplatinum Compounds; Polymers; Porosity; Succinates; Topotecan | 2017 |
The role of therapeutic drug monitoring in the management of safety of anticancer agents: a focus on 3 cytotoxics.
Topics: Antineoplastic Agents; Busulfan; Dose-Response Relationship, Drug; Drug Monitoring; Fluorouracil; Humans; Methotrexate; Neoplasms; Practice Guidelines as Topic; Precision Medicine | 2019 |
2 trial(s) available for fluorouracil and busulfan
Article | Year |
---|---|
A randomized study of single agent vs combination chemotherapy in FIGO stages IIB, III and IV ovarian adenocarcinoma.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Middle Aged; Ovarian Neoplasms; Random Allocation | 1985 |
A prospective, randomized, national trial for treatment of ovarian cancer: the role of chemotherapy and external irradiation.
Topics: Abdomen; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Busulfan; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Female; Finland; Fluorouracil; Follow-Up Studies; Humans; Middle Aged; Ovarian Neoplasms; Pelvis; Prospective Studies; Random Allocation; Vincristine | 1984 |
49 other study(ies) available for fluorouracil and busulfan
Article | Year |
---|---|
Synthesis and preliminary biological evaluations of CC-1065 analogues: effects of different linkers and terminal amides on biological activity.
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Apoptosis; Benzofurans; DNA; Drug Screening Assays, Antitumor; Duocarmycins; Heterocyclic Compounds, 4 or More Rings; Indoles; Leucomycins; Leukocyte Count; Male; Mice; Neoplasm Transplantation; Platelet Count; Structure-Activity Relationship; Tumor Cells, Cultured | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations.
Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Increased urinary excretion of nucleic acid and nicotinamide derivatives by rats after treatment with alkylating agents.
Topics: 2-Acetylaminofluorene; Alkylating Agents; Animals; Benz(a)Anthracenes; Busulfan; Chromatography, Thin Layer; Cytarabine; Deoxycytidine; Dichlorvos; Dimethylnitrosamine; Ethyl Methanesulfonate; Female; Fluorouracil; Hydrocarbons, Brominated; Mechlorethamine; Methylguanidine; Niacinamide; Nitrosourea Compounds; Rats; Thymidine; Uric Acid | 1975 |
A long lasting proliferative defect in the hematopoietic stem cell compartment following cytotoxic agents.
Topics: Animals; Antineoplastic Agents; Bone Marrow Transplantation; Busulfan; Cell Division; Cyclophosphamide; Fluorouracil; Hematopoietic Stem Cells; Male; Melphalan; Mice; Mice, Inbred C3H; Time Factors; Transplantation, Isogeneic | 1979 |
Sister-chromatid exchanges and chromosal breakage in patients treated with cytostatics.
Topics: Bromodeoxyuridine; Busulfan; Chromatids; Chromosome Aberrations; Cyclophosphamide; Doxorubicin; Fluorouracil; Humans; Neoplasms | 1979 |
Nature of the hemopoietic stem cell compartment and its proliferative potential.
Topics: Animals; Bone Marrow Cells; Busulfan; Cell Division; Cyclophosphamide; Cytarabine; Fluorouracil; Hematopoietic Stem Cells; Mice; Models, Biological | 1979 |
[Polychemotherapy in patients following radical surgery for bronchial carcinoma].
Topics: Bronchial Neoplasms; Busulfan; Cyclophosphamide; Drug Therapy, Combination; Drug Tolerance; Fluorouracil; Humans; Methotrexate; Postoperative Complications; Prognosis; Vinblastine | 1977 |
[Side effects of cytostatic therapy in childhood].
Topics: Adolescent; Antineoplastic Agents; Asparaginase; Busulfan; Child; Child, Preschool; Cyclophosphamide; Cytarabine; Dactinomycin; Daunorubicin; Female; Fluorouracil; Humans; Male; Mannitol; Mercaptopurine; Methotrexate; Prednisone; Procarbazine; Time Factors; Triaziquone; Vinblastine; Vincristine | 1976 |
Screening of cytotoxic drugs for residual bone marrow damage.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Bone Marrow Diseases; Busulfan; Carmustine; Cell Survival; Cyclophosphamide; Drug Evaluation, Preclinical; Female; Fluorouracil; Hematopoietic Stem Cells; Mercaptopurine; Methotrexate; Mice; Mice, Inbred BALB C; Vinblastine | 1976 |
Stimulatory effect of staphylococcal leukocidin on granulopoiesis disturbed by cytostatic agents.
Topics: Animals; Bone Marrow; Busulfan; Fluorouracil; Granulocytes; Hematopoiesis; Leukocidins; Leukocytes; Rabbits; Staphylococcus | 1976 |
Effect of some antineoplastics on metabolic heme pathway.
Topics: 5-Aminolevulinate Synthetase; Animals; Antineoplastic Agents; Busulfan; Chick Embryo; Cyclophosphamide; Fluorouracil; Heme; Liver; Porphyrins | 1988 |
Patterns of recovery of high proliferation potential colony-forming cells after stressing the haemopoietic system--I.
Topics: Animals; Busulfan; Cell Division; Clone Cells; Female; Fluorouracil; Hematopoiesis; Hematopoietic Stem Cells; Male; Mice | 1987 |
Development of latent residual drug damage to the hematopoietic marrow during the subsequent growth of tumors.
Topics: Animals; Antineoplastic Agents; Bone Marrow; Busulfan; Cisplatin; Colony-Forming Units Assay; Doxorubicin; Erythrocytes; Fluorouracil; Hematopoietic Stem Cells; Male; Mice; Neoplasms, Experimental; Time Factors | 1986 |
Acceleration of casein induced amyloidosis in mice by immunosuppressive agents.
Topics: Amyloid; Amyloidosis; Animals; Azathioprine; Busulfan; Caseins; Chloramphenicol; Cortisone; Dactinomycin; Daunorubicin; DNA; Female; Fluorouracil; Immunosuppressive Agents; Liver; Male; Mercaptopurine; Methotrexate; Mice; RNA; Spleen; Vinblastine | 1971 |
Proceedings: Cancer of the prostate.
Topics: Amides; Antineoplastic Agents; Arginase; Bleomycin; Busulfan; Carbamates; Chromomycins; Cyclic P-Oxides; Cyclohexanes; Cyclophosphamide; Dactinomycin; Dimethylamines; Drug Evaluation, Preclinical; Estranes; Ethylamines; Fluorouracil; Humans; Imidazoles; Male; Mitomycins; Nitrogen Mustard Compounds; Nitrosourea Compounds; Organophosphorus Compounds; Oxidoreductases; Plicamycin; Procarbazine; Prostate; Prostatic Neoplasms; Streptozocin; Triazines; Uracil Mustard; Vincristine | 1973 |
Chemotherapy of induced skin tumors in mice.
Topics: Alkylating Agents; Animals; Antimetabolites; Antineoplastic Agents; Benz(a)Anthracenes; Busulfan; Carcinoma, Squamous Cell; Chlorambucil; Cortisone; Cyclophosphamide; Dactinomycin; Estradiol; Female; Fluorouracil; Hydroxyurea; Mercaptopurine; Methotrexate; Mice; Mitomycins; Neoplasms, Experimental; Nitrogen Mustard Compounds; Nitroso Compounds; Papilloma; Skin Neoplasms; Testosterone; Triethylenemelamine | 1968 |
Chemotherapy studies in an animal tumor spectrum. II. Sensitivity of tumors to fourteen antitumor chemicals.
Topics: Animals; Antineoplastic Agents; Arsenicals; Busulfan; Cyclophosphamide; Dactinomycin; Diethylstilbestrol; Floxuridine; Fluorouracil; Hydrocortisone; Mercaptopurine; Methotrexate; Mice; Mitomycins; Neoplasms, Experimental; Urethane; Vinblastine | 1966 |
Myeloid leukemia C-1498 as a screen for cancer chemotherapeutic agents.
Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Azaguanine; Azaserine; Busulfan; Cyclophosphamide; Dactinomycin; Female; Floxuridine; Fluorouracil; Leukemia, Experimental; Mercaptopurine; Methotrexate; Mice; Neoplasms, Experimental; Prednisone; Pyrazoles; Pyrimidines; Triethylenemelamine; Vinblastine; Vincristine | 1966 |
[Effects of combined cytoxic agents on the bone marrow].
Topics: Animals; Antineoplastic Agents; Bone Marrow; Busulfan; Chlorambucil; Cyclophosphamide; Drug Synergism; Fluorouracil; Rats; Vinblastine | 1966 |
Current problems in the use of the oncolytic drugs.
Topics: Antineoplastic Agents; Busulfan; Carcinoma, Squamous Cell; Child; Chlorambucil; Choriocarcinoma; Dactinomycin; Female; Fluorouracil; Gonadal Steroid Hormones; Hodgkin Disease; Humans; Hydrazines; Leukemia; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Mercaptopurine; Mesenchymoma; Methotrexate; Multiple Myeloma; Nitrogen Mustard Compounds; Ovarian Neoplasms; Pregnancy; Prostatic Neoplasms; Steroids; Testicular Neoplasms; Urethane; Vinblastine; Vincristine; Wilms Tumor | 1968 |
[Proof of mutagenicity of foreign substances].
Topics: Animals; Busulfan; Carcinogens; Chromosome Aberrations; Drug Tolerance; Female; Fluorouracil; Genes, Dominant; Genes, Lethal; Humans; Male; Mammals; Mesylates; Mice; Mitomycins; Mutagens; Rats; Spermatozoa | 1973 |
Enhancement of antitumor effect of cyclophosphamide by centrophenoxine.
Topics: Acetates; Animals; Antineoplastic Agents; Busulfan; Central Nervous System Stimulants; Cyclophosphamide; Drug Synergism; Fluorouracil; Meclofenoxate; Mercaptopurine; Methotrexate; Mice; Mitomycins; Sarcoma 180; Vinblastine; Vincristine | 1971 |
Peripheral nucleated cell count as a method of assessing the response of antileukemic agents in Rauscher virus-diseased mice.
Topics: Animals; Antineoplastic Agents; Blood; Busulfan; Carbamates; Cell Count; Chlorambucil; Cyclophosphamide; Dose-Response Relationship, Drug; Ethylamines; Fluorouracil; Lethal Dose 50; Leukemia, Experimental; Male; Mercaptopurine; Methotrexate; Mice; Nitrogen Mustard Compounds; Propylamines; Rauscher Virus; Sulfanilamides | 1973 |
[Chemotherapy of cancer. Hints for continuing medical education].
Topics: Antineoplastic Agents; Busulfan; Chlorambucil; Cyclophosphamide; Cytarabine; Daunorubicin; Education, Medical, Continuing; Fluorouracil; Humans; Melphalan; Mercaptopurine; Methotrexate; Neoplasms; Procarbazine; Triaziquone; Vinblastine; Vincristine | 1974 |
Sensitivity of Nakahara-Fukuoka sarcoma to antitumor agents, especially to purine analogs.
Topics: Animals; Antineoplastic Agents; Busulfan; Cyclophosphamide; Female; Fluorouracil; Hydrocortisone; Mechlorethamine; Mercaptopurine; Methotrexate; Mice; Mitomycins; Purines; Sarcoma, Experimental; Thioguanine; Thiotepa; Uracil | 1969 |
[Animal experimental studies on the immunosuppressive effect of cytostatic agents].
Topics: Animals; Antineoplastic Agents; Busulfan; Carcinogens; Cyclophosphamide; Fluorouracil; Hemagglutination Tests; Immunosuppressive Agents; Male; Mannomustine; Mercaptopurine; Methotrexate; Mitomycins; Rats; Spleen; Thiotepa; Triaziquone; Vinblastine | 1969 |
[The effect of various cytostatic drugs on the growth of 12 chosen mycobacterial strains].
Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antimetabolites; Antineoplastic Agents; Busulfan; Chemical Phenomena; Chemistry; Culture Media; Drug Resistance, Microbial; Fluorouracil; Mercaptopurine; Methotrexate; Mitomycins; Mycobacterium; Species Specificity | 1971 |
[Antiblastic effect of various chemotherapeutic preparations on the cells of the Ehrlich ascites tumor].
Topics: Animals; Antibiotics, Antineoplastic; Antineoplastic Agents; Busulfan; Carcinoma, Ehrlich Tumor; Fluorouracil; Mechlorethamine; Melphalan; Mercaptopurine; Mice; Nitrogen Mustard Compounds; Uracil | 1966 |
Transient and permanent engraftment potential of murine hematopoietic stem cell subsets: differential effects of host conditioning with gamma radiation and cytotoxic drugs.
Topics: Animals; Bone Marrow Cells; Busulfan; Cell Division; Cells, Cultured; Chimera; Erythroid Precursor Cells; Fluorouracil; Gamma Rays; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Male; Mice; Mice, Inbred C57BL; Plant Lectins; Thymus Gland; Wheat Germ Agglutinins; Whole-Body Irradiation | 1993 |
Disruptions of the hypothalamo-pituitary-adrenal axis increase anticancer drug lethality in the rat.
Topics: Adrenalectomy; Animals; Antineoplastic Agents; Busulfan; Carmustine; Corticosterone; Cosyntropin; Cyclophosphamide; Fluorouracil; Hypophysectomy; Hypothalamo-Hypophyseal System; Male; Pituitary-Adrenal System; Rats; Rats, Wistar; Vindesine | 1997 |
Changes in erythropoietin pharmacokinetics following busulfan-induced bone marrow ablation in sheep: evidence for bone marrow as a major erythropoietin elimination pathway.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Bone Marrow; Busulfan; Erythropoietin; Fluorouracil; Half-Life; Iodine Radioisotopes; Recombinant Proteins; Sheep | 2001 |
[A novel rat aplastic anemia model induced by 5-fluorouracil combined with busulfan].
Topics: Anemia, Aplastic; Animals; Blood Cell Count; Busulfan; Disease Models, Animal; Female; Fluorouracil; Humans; Injections, Intraperitoneal; Rats; Rats, Wistar | 2001 |
[Activation of auto-mesenchymal stem cells of skeletal muscle by bone morphogenetic protein for rescuing bone marrow failure].
Topics: Anemia, Aplastic; Animals; Bone Morphogenetic Proteins; Busulfan; Cell Differentiation; Female; Fluorouracil; Hematopoiesis; Hematopoietic Stem Cells; Implants, Experimental; Male; Mice; Muscle, Skeletal; Rats; Rats, Wistar; Recombinant Proteins; Stem Cells | 2002 |
DRUGS OF CURRENT USE FOR THE TREATMENT OF CANCER AND ALLIED DISEASES.
Topics: Adrenal Cortex Hormones; Anti-Bacterial Agents; Antineoplastic Agents; Aziridines; Busulfan; Colchicine; Dactinomycin; Diethylstilbestrol; Estrogens; Fluorouracil; Gonadal Steroid Hormones; Mercaptopurine; Methotrexate; Mitomycin; Mitomycins; Neoplasms; Podophyllum; Progestins; Quinones; Thiotepa; Triethylenemelamine; Urethane; Vinblastine | 1963 |
Mesenchymal stem cells derived from different origins have unique sensitivities to different chemotherapeutic agents.
Topics: Adipose Tissue; Animals; Antineoplastic Agents; Apoptosis; Bone Marrow Cells; Busulfan; Cell Proliferation; Cell Survival; Cellular Senescence; Doxorubicin; Fluorouracil; Gene Expression; Gene Expression Regulation; Mesenchymal Stem Cells; Methotrexate; Rats; Rats, Sprague-Dawley | 2012 |
Synergistic cytotoxic activity of treosulfan and gemcitabine in pancreatic cancer cell lines.
Topics: Antineoplastic Agents; Busulfan; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Dose-Response Relationship, Drug; Drug Antagonism; Drug Synergism; Fluorouracil; Gemcitabine; Humans; Pancreatic Neoplasms | 2014 |
Suppressive effects of low-dose 5-fluorouracil, busulfan or treosulfan on the expansion of circulatory neutrophils and myeloid derived immunosuppressor cells in tumor-bearing mice.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Busulfan; Cell Line, Tumor; Drug Interactions; Female; Fluorouracil; Immunosuppressive Agents; Leukocyte Count; Lymphoma; Mice, Inbred C57BL; Myeloid Cells; Spleen; Tumor Burden | 2016 |
Dnmt3a-null hematopoietic stem and progenitor cells expand after busulfan treatment.
Topics: Animals; Bone Marrow; Busulfan; Cell Division; Cell Lineage; Clone Cells; DNA (Cytosine-5-)-Methyltransferases; DNA Methyltransferase 3A; Fluorouracil; Hematopoiesis; Hematopoietic Cell Growth Factors; Hematopoietic Stem Cell Mobilization; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Mice; Radiation Chimera | 2020 |
Development and application of a liquid chromatography coupled to mass spectrometry method for the simultaneous determination of 23 antineoplastic drugs at trace levels.
Topics: Antineoplastic Agents; Busulfan; Carboplatin; Chromatography, Liquid; Cyclophosphamide; Cytarabine; Dacarbazine; Daunorubicin; Docetaxel; Doxorubicin; Epirubicin; Etoposide; Fluorouracil; Ganciclovir; Humans; Idarubicin; Ifosfamide; Irinotecan; Methanol; Methotrexate; Oxaliplatin; Paclitaxel; Pemetrexed; Tandem Mass Spectrometry; Topotecan; Vinblastine; Vincristine; Water | 2022 |